Mitroflow receives PMDA approval; launches in Japan

Sorin has received the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow aortic pericardial heart valve. The product will be distributed in Japan by Japan Lifeline Company.

With the pericardium layer mounted on the outside of valve stent, the Mitroflow valve maximises the internal orifice area, allowing for maximum valve opening with no obstruction to blood flow and an unimpeded leaflet opening. The valve is said to deliver excellent haemodynamic performance with low pressure gradients, large effective orifice areas and left ventricular mass regression also in patients with small annuli.

Mitroflow receives PMDA approval; launches in Japan

Sorin has received the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow aortic pericardial heart valve. The product will be distributed in Japan by Japan Lifeline Company.

With the pericardium layer mounted on the outside of valve stent, the Mitroflow valve maximises the internal orifice area, allowing for maximum valve opening with no obstruction to blood flow and an unimpeded leaflet opening. The valve is said to deliver excellent haemodynamic performance with low pressure gradients, large effective orifice areas and left ventricular mass regression also in patients with small annuli.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.